Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production

DOI PDF 2 Citations

Search this article

Journal

  • Rheumatology

    Rheumatology 47 (7), 1104-1105, 2008-04-25

    Oxford University Press (OUP)

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top